⌘K
Loading ticker…
Bioventus Inc. Class A Common Stock · Healthcare · Medical Equipment
As of 2026-06-26, Bioventus Inc. Class A Common Stock (BVS) has a 3-month relative strength percentile of 51 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 57. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.5%, relative volume 2.17×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
51 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
BVS is in a stage 2 uptrend, week 1. Currently in a 25-day base; basing ADR 5.1% (broad 4.4%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 2.0% / 18.7%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
BVS is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $11M notional. Top 3 carry $26M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $11M |
| IWMiShares Russell 2000 ETF | 0.01% | $10M |
| VXFVanguard Extended Market ETF | 0.01% | $5M |
| IWOiShares Russell 2000 Growth ETF | 0.03% | $3M |
| XHEState Street SPDR S&P Health Care Equipment ETF | 0.33% | $446K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BVS Jan avg: -8.56% median: -7.97% win: 50% σ: 15.11% n: 4 2022-04-12 → 2026-05-29 | BVS Feb avg: 5.25% median: 7.68% win: 75% σ: 7.07% n: 4 2022-04-12 → 2026-05-29 | BVS Mar avg: -10.81% median: -2.89% win: 50% σ: 27.52% n: 4 2022-04-12 → 2026-05-29 | BVS Apr avg: -9.64% median: -6.74% win: 20% σ: 12.76% n: 5 2022-04-12 → 2026-05-29 | BVS May avg: 38.75% median: -11.35% win: 40% σ: 80.69% n: 5 2022-04-12 → 2026-05-29 | BVS Jun avg: -9.01% median: -5.95% win: 50% σ: 17.16% n: 4 2022-04-12 → 2026-05-29 (current) | BVS Jul avg: 17.54% median: 23.20% win: 75% σ: 12.78% n: 4 2022-04-12 → 2026-05-29 | BVS Aug avg: 10.60% median: 6.47% win: 50% σ: 24.54% n: 4 2022-04-12 → 2026-05-29 | BVS Sep avg: -0.82% median: -6.29% win: 25% σ: 13.35% n: 4 2022-04-12 → 2026-05-29 | BVS Oct avg: 10.20% median: 13.29% win: 75% σ: 8.31% n: 4 2022-04-12 → 2026-05-29 | BVS Nov avg: -15.59% median: -1.10% win: 50% σ: 41.65% n: 4 2022-04-12 → 2026-05-29 | BVS Dec avg: 12.26% median: 14.89% win: 50% σ: 24.28% n: 4 2022-04-12 → 2026-05-29 |